Dr. Lal Path Labs · NSE: LALPATHLAB · BSE: 539524
Q4 FY22 results · Jan–Mar 2022
Dr. Lal Path Labs reported revenue from operations of ₹485.50 crore (up 12.6% from Q4 FY21) and net profit of ₹62.10 crore (down 27.0% from Q4 FY21) for Q4 FY22 (Jan–Mar 2022), on a consolidated basis.
| Item | Q4 FY22 | Q4 FY21 | YoY | Q3 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 485.50 | 431.00 | +12.6% | 496.90 | −2.3% |
| Other income | 12.00 | 13.50 | −11.1% | 12.10 | −0.8% |
| Total income | 497.50 | 444.50 | +11.9% | 509.00 | −2.3% |
| Profit before tax | 83.50 | 110.80 | −24.6% | 81.50 | +2.5% |
| Net profit for the period | 62.10 | 85.10 | −27.0% | 58.20 | +6.7% |
| Attributable to shareholders of the company | 61.30 | 83.40 | −26.5% | 57.30 | +7.0% |
| EPS, basic (₹) | 7.41 | 10.10 | −26.6% | 6.93 | +6.9% |
| Net margin (%) | 12.8 | 19.7 | 11.7 |
| Item | Q4 FY22 | Q4 FY21 | YoY | Q3 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 414.90 | 404.10 | +2.7% | 422.50 | −1.8% |
| Other income | 12.90 | 13.10 | −1.5% | 11.30 | +14.2% |
| Total income | 427.80 | 417.20 | +2.5% | 433.80 | −1.4% |
| Profit before tax | 85.10 | 104.70 | −18.7% | 83.20 | +2.3% |
| Net profit for the period | 65.20 | 78.70 | −17.2% | 61.70 | +5.7% |
| EPS, basic (₹) | 7.88 | 9.52 | −17.2% | 7.46 | +5.6% |
| Net margin (%) | 15.7 | 19.5 | 14.6 |
Consolidated
- Filed with BSE
- 17 May 2022, 18:34 IST
- Board meeting
- 17 May 2022
- Period
- 01 Jan 2022 to 31 Mar 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 17 May 2022, 18:34 IST
- Board meeting
- 17 May 2022
- Period
- 01 Jan 2022 to 31 Mar 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE